Tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone
C82H102BN11O9 — CID 158898196
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone
Tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone (PubChem CID 158898196) has the molecular formula C82H102BN11O9 and a molecular weight of 1396.60 g/mol. Its IUPAC name is tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone.
Molecular Properties
| Compound Name | Tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone |
|---|---|
| PubChem CID | 158898196 |
| Molecular Formula | C82H102BN11O9 |
| Molecular Weight | 1396.60 g/mol |
| Exact Mass | 1395.80 |
| IUPAC Name | tert-butyl 2-[(1R)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate;(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-amine;2-[(1R)-4-[6-[5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinolin-3-yl]cyclohex-3-en-1-yl]-1-[(2S)-pyrrolidin-2-yl]ethanone |
| SMILES | CC(C)(C)OC(=O)C[C@H]1CC=C(B2OC(C)(C)C(C)(C)O2)CC1.CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)O.Cc1cccc(-c2[nH]cnc2-c2ccc3ncc(C4=CC[C@H](CC(=O)[C@@H]5CCCN5)CC4)cc3c2)n1.Cc1cccc(-c2[nH]cnc2-c2ccc3ncc(C4=CC[C@H](N)CC4)cc3c2)n1 |
| InChI | InChI=1S/C30H31N5O.C24H23N5.C18H31BO4.C10H17NO4/c1-19-4-2-5-27(35-19)30-29(33-18-34-30)22-11-12-25-23(15-22)16-24(17-32-25)21-9-7-20(8-10-21)14-28(36)26-6-3-13-31-26;1-15-3-2-4-22(29-15)24-23(27-14-28-24)17-7-10-21-18(11-17)12-19(13-26-21)16-5-8-20(25)9-6-16;1-16(2,3)21-15(20)12-13-8-10-14(11-9-13)19-22-17(4,5)18(6,7)23-19;1-10(2,3)15-9(14)11-6-4-5-7(11)8(12)13/h2,4-5,9,11-12,15-18,20,26,31H,3,6-8,10,13-14H2,1H3,(H,33,34);2-5,7,10-14,20H,6,8-9,25H2,1H3,(H,27,28);10,13H,8-9,11-12H2,1-7H3;7H,4-6H2,1-3H3,(H,12,13)/t20-,26-;20-;13-;7-/m0000/s1 |
| InChIKey | JFCHWZKRIFOQII-KHRMGXFMSA-N |
| XLogP | 16.33 |
| TPSA | 275.64 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 103 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1396.60 |
| LogP ≤ 5 | 16.33 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158898196 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.